AUG 25, 2015 5:10 PM PDT

Plant Extract Takes on MRSA

WRITTEN BY: Kerry Evans
Cassandra Quave, Ph.D., has built a career on the medicinal properties of plants.  The Emory University ethnobotanist is particularly interested in plant extracts that could be used to treat bacterial infections. Quave and University of Iowa microbiologist Alexander Horswill, Ph.D., identified chemicals from chestnut leaves (Castanea sativa) that decrease toxin production by methicillin-resistant Staphylococcus aureus (MRSA). 

Chestnut leaf extracts attenuate MRSA.
The team distilled chemicals from the chestnut leaves and identified 94 compounds that were active against the bacteria.  The chemicals, derivatives of ursene and oleanene, disrupt the agr pathway, a key quorum sensing pathway the bacteria use to communicate with each other and produce virulence factors such as toxins.  They published their findings in the journal PLOS ONE.

“Rather than killing Staph, this botanical extract works by taking away Staph’s weapons, essentially shutting off the ability of the bacteria to create toxins that cause tissue damage.  In other words, it takes the teeth out of the bacteria’s bite.”

The chestnut extract works by antagonizing the S. aureus “accessory gene regulator” (agr) system.  This system regulates virulence factor production through the quorum sensing molecule AIP.  An excess of AIP signals the bacteria to produce virulence factors such as toxins.

The extract cleared MRSA skin lesions in mice without affecting healthy tissue or normal skin flora.  Importantly, the bacteria did not become resistant to the extract, even after long-term exposure.

An obvious drawback is that these extracts do not actually kill the bacteria, they only attenuate virulence.  This means that antibiotics would need to be used in conjunction with the extracts, an obvious roadblock when treating antibiotic-resistant bacteria.

Despite this shortcoming, Quave is hopeful.  “We now have a mixture that works”, she says, “our goal is to further refine it into a simpler compound that would be eligible for FDA consideration as a therapeutic agent”.



Sources: PLOS ONE, Science Daily
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
AUG 24, 2020
Cell & Molecular Biology
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
AUG 24, 2020
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
Researchers know that the viruses including SARS-CoV-2 have a Spike protein that allows them to bind to receptors on hos ...
SEP 01, 2020
Cell & Molecular Biology
Smell Cells Are Especially Good at Fighting the Flu
SEP 01, 2020
Smell Cells Are Especially Good at Fighting the Flu
All over the body, cells line organs and vessels, forming protective barriers. But pathogens like the flu have gained th ...
SEP 23, 2020
Microbiology
Poxvirus Made Harmless After Removing One Gene
SEP 23, 2020
Poxvirus Made Harmless After Removing One Gene
Poxviruses are deadly viruses that are known to infect both animals and humans. Cowpox and monkeypox are both known to s ...
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
OCT 28, 2020
Microbiology
Immune Cells Link Gum Disease to Inflammatory DIsorders
OCT 28, 2020
Immune Cells Link Gum Disease to Inflammatory DIsorders
Scientists and clinicians know that oral health and inflammation, which is a part of many diseases, are connected.
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
Loading Comments...